The research team led by Chen Naihong, a professor at Hubei University of Chinese Medicine, published the results in Translational Research (IMM-H004 Therapy for permanent Focal injury via CKLF1/CCR4-mediated NLRP3 Masome Activation) October 2019, Pages 3